Physician profile
Timothy Huff
NPI 1205214426
$1,617.61
in general payments reported to CMS, 2019-2025
18 companies · $538 in 2025
The $538 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $276 · 2023: $169 · 2024: $302 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.81 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $235.88 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Novo Nordisk INC | $213.48 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $126.55 | 2021-2024 | Mounjaro, Zepbound |
| Vanda Pharmaceuticals INC. | $118.81 | 2025 | Fanapt, Hetlioz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.52 | 2021-2025 | Jardiance |
| Genzyme Corporation | $104.37 | 2024-2025 | |
| Glaxosmithkline, LLC. | $102.43 | 2022-2023 | Trelegy Ellipta |
| Pfizer INC. | $95.92 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $78.54 | 2024-2025 | Dupixent |
| Exact Sciences Corporation | $19.65 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $17.63 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.67 | 2025 | Xifaxan |
| Amgen INC. | $16.02 | 2024 | Repatha |
| Merck Sharp & Dohme LLC | $16.02 | 2023 | Proquad, Vaxelis, Vaqta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $14.73 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.86 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.